To our knowledge, there are few reports demonstrating cancer cell-mediated autocrine or paracrine secretion of TRAIL induced by the treatment of low molecule compounds: all-trans retinoic acid induced TRAIL in a paracrine mode in leukemia cells [50], while HDAC inhibitor MS275 induced endogenic TRAIL in several breast cancer cells [51]. This evidence concerns the gene TNFSF10 and breast cancer.